| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/26/2002 | WO2002074231A2 Cosmetic and dermopharmaceutical compositions comprising standardised extracts of hierochloe odorata |
| 09/26/2002 | WO2002074200A1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 09/26/2002 | WO2002074196A1 Ocular therapeutic agent delivery devices and methods for making and using such devices |
| 09/26/2002 | WO2002074193A2 METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN ss4 (Tss4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES |
| 09/26/2002 | WO2002074158A2 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 09/26/2002 | WO2002074099A2 Polybutene containing chewing gum and confection |
| 09/26/2002 | WO2002074034A2 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 09/26/2002 | WO2002056843A3 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or ophthalmological fields |
| 09/26/2002 | WO2002045752A3 Dermal anti-inflammatory composition |
| 09/26/2002 | WO2002043800A3 Devices and methods for controlled delivery from a drug delivery device |
| 09/26/2002 | WO2002043566A3 Devices and methods for treating low blood sugar levels |
| 09/26/2002 | WO2002036167A8 Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids |
| 09/26/2002 | WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation |
| 09/26/2002 | WO2002028180A3 Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof |
| 09/26/2002 | WO2002026277A3 Stabilized hydrogen peroxide solutions |
| 09/26/2002 | WO2002024174A3 Sustained release composition containing clarithromycin |
| 09/26/2002 | WO2002015880A3 Powdered mannitol and mannitol-containing compositions |
| 09/26/2002 | WO2001085093A9 Compounds and methods for modulating cerebral amyloid angiopathy |
| 09/26/2002 | WO2001080837A2 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 09/26/2002 | WO2001076635A1 Preparations for preventing bile acid diarrhea |
| 09/26/2002 | WO2001074338A1 Transdermal therapeutic system for the delivery of lerisetron |
| 09/26/2002 | WO2001074331A1 Oily compositions containing highly fat-soluble drugs |
| 09/26/2002 | WO2001070206B1 Combination of lecithin with ascorbic acid |
| 09/26/2002 | WO2001040370A3 Ionically crosslinked hydrogels with adjustable gelation time |
| 09/26/2002 | WO2001034119A9 Inhibitors of crystallization in a solid dispersion |
| 09/26/2002 | WO2001019385A9 The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses |
| 09/26/2002 | WO2000061112A3 Solubilized pharmaceutical composition for parenteral administration |
| 09/26/2002 | US20020138068 Implantable refillable and ported controlled release drug delivery device |
| 09/26/2002 | US20020138067 Microchip reservoir devices and facilitated corrosion of electrodes |
| 09/26/2002 | US20020138049 Microneedle devices and methods of manufacture and use thereof |
| 09/26/2002 | US20020138043 Gasket for bypass type prefilled syringe |
| 09/26/2002 | US20020137884 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 09/26/2002 | US20020137803 Composition and method for delivering active agents |
| 09/26/2002 | US20020137790 Method for the production and use of a cream containing vitamin-A |
| 09/26/2002 | US20020137777 Benzothiazole, riluzole, phenylbenzothiazole or lifarizine as blocking agents to limit sodium/calcium exchange in the retinal ganglion cells |
| 09/26/2002 | US20020137771 Mixing benzimidazole derivatives with basic inorganic salt stabilizing agent, granulating and enteric coating granules; gastric acid secretion inhibitors |
| 09/26/2002 | US20020137765 Sustained release formulations for growth hormone secretagogues |
| 09/26/2002 | US20020137764 .0005-5 wt% of a tiotropium salt, an antiallergic, antihistamine, steroid, or leukotriene antagonist, water or water/ethanol mixture and a preservative; antiasthmatics and chronic obstructive pulmonary disease treatment |
| 09/26/2002 | US20020137754 Oxazolidinone thioamides with piperazine amide substituents |
| 09/26/2002 | US20020137749 Formulation for menopausal women |
| 09/26/2002 | US20020137729 For minimizing the absorption of triglycerides and fats in the gastrointestinal tract; fat binding; treating obesity |
| 09/26/2002 | US20020137727 Forming a powder blend of active ingredient with diluents, wet granulating with water, compressing the lubricated granule mixture into tablet form; alendronic acid dosage forms |
| 09/26/2002 | US20020137691 Supplement collagen and elastic tissues and thicken the dermis; administering a sugar compound converting mucopoly-saccharides; enzyme inhibitor of collangenase/elastase; an amino acid; fat burner, vaso-dilator and chromium picolinate |
| 09/26/2002 | US20020137685 For production of antiinflammatory peptides |
| 09/26/2002 | US20020137221 Method of preserving oxygen infusions |
| 09/26/2002 | US20020137156 Controlled dissolution crosslinked protein crystals |
| 09/26/2002 | US20020137122 Ligand-specific opening of a gated-porin channel in the outer membrane of living bacteria |
| 09/26/2002 | US20020136800 1-20 wt% of lactase and cutting agent that is 0-4 parts by weight for each part by weight lactase, 1-98 wt% of microcrystalline cellulose, 0-97 wt% of mannitol, and a lubricant to aid in compression |
| 09/26/2002 | US20020136787 Method of treating prickly heat |
| 09/26/2002 | US20020136786 Composition and method for smoke detoxification |
| 09/26/2002 | US20020136777 Three days old silkworms are freeze-dried, are powdered, extracted with methanol, and low pressure condensed, ginger extract, cinnamon bark extract, vitamin c, citric acid, and teurine |
| 09/26/2002 | US20020136776 Poly( alpha -hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, and the like, and are formed using cationic, anionic, or nonionic detergents |
| 09/26/2002 | US20020136775 Aldosterone receptor blockers |
| 09/26/2002 | US20020136774 Luteinizing hormone in an administrable form which ensures an increase in plasma levels for 40-60 hours |
| 09/26/2002 | US20020136773 Solid permeable shell of a polymer resin having surface modifying compounds that can react with isocyanates |
| 09/26/2002 | US20020136772 Polymer synthesis |
| 09/26/2002 | US20020136771 Stabilized ascorbic acid composition |
| 09/26/2002 | US20020136770 Method of delivering active material within hydrogel microbeads |
| 09/26/2002 | US20020136769 Nanogel networks including polyion polymer fragments and biological agent compositions thereof |
| 09/26/2002 | US20020136768 Quaternary ammonium compound, a hydrophilic film-forming agent, a hydrophobic waterproofing agent, a surfactant, and water for hand washing |
| 09/26/2002 | US20020136767 Controlling particle size of volatile excipients to </= 70 microns |
| 09/26/2002 | US20020136766 Doxycycline administered in three dosages forms of different release profiles, with Cmax being reached in < twelve hours |
| 09/26/2002 | US20020136765 Fluroquinilone antibiotic product, use and formulation thereof |
| 09/26/2002 | US20020136764 Antibiotic product, use and formulation thereof |
| 09/26/2002 | US20020136763 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 09/26/2002 | US20020136762 Lyophilized liposomes of at least two sizes are absorbed in the Peyer's patches of the gut of a mammal and are taken up by macrophages |
| 09/26/2002 | US20020136761 Ribonucleotide-oligonucleotide with a specific sequence that binds to both the negative and positive strands of influenza RNA |
| 09/26/2002 | US20020136760 Carboxylated phosphatidic acid esters |
| 09/26/2002 | US20020136758 Patch for transdermal therapy |
| 09/26/2002 | US20020136757 Preventing HIV vaginally or rectally by contacting a bodily fluid with polyquaternium, glycerin and a preservative system |
| 09/26/2002 | US20020136753 Oolong tea extract; antiinflammatories, anti-atopic dermatitis agent or antipsoriatic agent |
| 09/26/2002 | US20020136752 Lipophilic medicament and a matrix with a self-emulsifying agent which when hydrated forms an emulsion that adheres reversibly to a mucosal surface for controlled release of the medicament |
| 09/26/2002 | US20020136750 Acidified nitrite as an antimicrobial agent |
| 09/26/2002 | US20020136746 Cosmetic compositions comprising alk(en)ylsuccinic acid derivatives |
| 09/26/2002 | US20020136744 Sustained release drug dispersion delivery device |
| 09/26/2002 | US20020136735 Preparations that potentiate immunogenicity in low immunogenic antigens |
| 09/26/2002 | US20020136731 Targeted therapeutic delivery of vitamin D compounds |
| 09/26/2002 | US20020136719 For biomedical applications, including biological delivery to humans and animals |
| 09/26/2002 | US20020136706 Providing particles of expanded matrix material to locus or vicinity of population of poultry during feed removal; particles contain bactericidal or bacteriostatic agents |
| 09/26/2002 | US20020136699 Rinsed or nonrinsed products particularly for hair washing, hair care, hair conditioning, hair dressing or hair setting. |
| 09/26/2002 | US20020136696 Orthopedic and dental ceramic implants |
| 09/26/2002 | US20020136695 Human medical treatment by aerosol inhalation of immunoglobulin A |
| 09/26/2002 | US20020136089 Mixing apparatus |
| 09/26/2002 | US20020135085 Production scale method of forming microparticles |
| 09/26/2002 | DE10113366A1 Medicament for treating inflammatory or obstructive respiratory diseases, e.g. asthma or chronic obstructive pulmonary disease, containing synergistic combination of anticholinergic agent and endothelin antagonist |
| 09/26/2002 | DE10110391A1 Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff Highly flexible nicotine transdermal therapeutic system with nicotine as a drug |
| 09/26/2002 | CA2469846A1 New interferon beta-like molecules |
| 09/26/2002 | CA2445486A1 Patch for transcutaneous immunization |
| 09/26/2002 | CA2441536A1 Polybutene containing chewing gum and confection |
| 09/26/2002 | CA2441530A1 Transcutaneous immunostimulation |
| 09/26/2002 | CA2441147A1 Methods of treating disorders of the eye and surrounding tissue with thymosin .beta.4 (t.beta.4), analogues, isoforms and other derivatives |
| 09/26/2002 | CA2441064A1 Controlled release sulfonylurea formulation |
| 09/26/2002 | CA2440844A1 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 09/26/2002 | CA2440261A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
| 09/26/2002 | CA2435825A1 New composition |
| 09/26/2002 | CA2434030A1 Stabilized formulation of selective ligands of retinoic acid gamma-receptors |
| 09/26/2002 | CA2431688A1 Implantable refillable and rate controlled drug delivery device |
| 09/26/2002 | CA2404581A1 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 09/26/2002 | CA2404422A1 Preparations for preventing bile acid diarrhea |
| 09/26/2002 | CA2404381A1 Oily compositions containing highly fat-soluble drugs |